56 related articles for article (PubMed ID: 10672955)
1. Diagnostic efficacy of systemic immune-inflammation biomarkers in benign prostatic hyperplasia using receiver operating characteristic and artificial neural network.
Ahmed R; Hamdy O; Awad RM
Sci Rep; 2023 Sep; 13(1):14801. PubMed ID: 37684320
[TBL] [Abstract][Full Text] [Related]
2. An examination of the dynamic changes in prostate-specific antigen occurring in a population-based cohort of men over time.
Inman BA; Zhang J; Shah ND; Denton BT
BJU Int; 2012 Aug; 110(3):375-81. PubMed ID: 22313933
[TBL] [Abstract][Full Text] [Related]
3. Detection of glypican-1 (GPC-1) expression in urine cell sediments in prostate cancer.
Campbell DH; Lund ME; Nocon AL; Cozzi PJ; Frydenberg M; De Souza P; Schiller B; Beebe-Dimmer JL; Ruterbusch JJ; Walsh BJ
PLoS One; 2018; 13(4):e0196017. PubMed ID: 29672570
[TBL] [Abstract][Full Text] [Related]
4. PREVALENCE OF BENIGN PROSTATIC HYPERPLASIA AND PROSTATE CANCER IN AFRICANS AND AFRICANS IN THE DIASPORA.
Yeboah ED
J West Afr Coll Surg; 2016; 6(4):1-30. PubMed ID: 29181363
[TBL] [Abstract][Full Text] [Related]
5. Evaluating the performance of ChatGPT in answering questions related to benign prostate hyperplasia and prostate cancer.
Caglar U; Yildiz O; Meric A; Ayranci A; Yusuf R; Sarilar O; Ozgor F
Minerva Urol Nephrol; 2023 Dec; 75(6):729-733. PubMed ID: 38126285
[TBL] [Abstract][Full Text] [Related]
6. Role of glutathione-S-transferase gene P1 in the diagnosis of prostate cancer in patients with 'grey level' prostate-specific antigen values.
Stan M; Botnarciuc V; Suceveanu AI; Mazilu L; Costea DO; Suceveanu AP; Serban D; Tudor C; Mitroi A; Brinzan C; Voinea F
Exp Ther Med; 2022 Sep; 24(3):591. PubMed ID: 35949339
[TBL] [Abstract][Full Text] [Related]
7. Phage Display's Prospects for Early Diagnosis of Prostate Cancer.
Petrenko VA
Viruses; 2024 Feb; 16(2):. PubMed ID: 38400052
[TBL] [Abstract][Full Text] [Related]
8. Chickpea Sprouts as a Potential Dietary Support in Different Prostate Disorders-A Preliminary In Vitro Study.
Galanty A; Prochownik E; Grudzińska M; Paśko P
Molecules; 2024 Feb; 29(5):. PubMed ID: 38474555
[TBL] [Abstract][Full Text] [Related]
9. An AFM-Based Model-Fitting-Free Viscoelasticity Characterization Method for Accurate Grading of Primary Prostate Tumor.
Liu N; Zhang T; Chen Z; Wang Y; Yue T; Shi J; Li G; Yang C; Jiang H; Sun Y
IEEE Trans Nanobioscience; 2024 Apr; 23(2):319-327. PubMed ID: 38194381
[TBL] [Abstract][Full Text] [Related]
10. Cellular Refractive Index Comparison of Various Prostate Cancer and Noncancerous Cell Lines via Photonic-Crystal Biosensor.
DeLuna F; Cadena M; Wang B; Sun LZ; Ye JY
Proc SPIE Int Soc Opt Eng; 2019 Feb; 10881():. PubMed ID: 32313355
[TBL] [Abstract][Full Text] [Related]
11. [Improved discrimination between prostatic carcinoma and benign prostatic hyperplasia by determination of free prostate-specific antigen percentage].
Wolff JM; Borchers H; Boeckmann W; Habib FK; Jakse G
Urologe A; 1997 May; 36(3):255-8. PubMed ID: 9265347
[TBL] [Abstract][Full Text] [Related]
12. [The incidence of the variability of the free PSA/total PSA ratio on the early diagnosis of prostate cancer].
de La Taille A; Houlgatte A; Houdelette P; Berlizot P; Fournier R; Ricordel I
Prog Urol; 1997 Jun; 7(3):455-63. PubMed ID: 9273075
[TBL] [Abstract][Full Text] [Related]
13. [Status of PSA determination for early detection of prostate carcinoma].
Hammerer P; Huland H
Versicherungsmedizin; 1995 Jun; 47(3):83-6. PubMed ID: 7541925
[TBL] [Abstract][Full Text] [Related]
14. Improved discrimination of prostate cancer and benign prostatic hyperplasia by means of the quotient of free and total PSA.
Weckermann D; Maassen C; Wawroschek F; Harzmann R
Int Urol Nephrol; 1999; 31(3):351-9. PubMed ID: 10672955
[TBL] [Abstract][Full Text] [Related]
15. In prostatism patients the ratio of human glandular kallikrein to free PSA improves the discrimination between prostate cancer and benign hyperplasia within the diagnostic "gray zone" of total PSA 4 to 10 ng/mL.
Kwiatkowski MK; Recker F; Piironen T; Pettersson K; Otto T; Wernli M; Tscholl R
Urology; 1998 Sep; 52(3):360-5. PubMed ID: 9730444
[TBL] [Abstract][Full Text] [Related]
16. [Usefulness of the percentage of free prostatic specific antigen in the differential diagnosis between benign prostatic hyperplasia and prostate cancer].
Gaspar MJ; Arribas I; Hontoria JM; Bokobo P; Coca C; Angulo JC
Med Clin (Barc); 2000 Sep; 115(9):332-6. PubMed ID: 11093893
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
